Mein Warenkorb

Vaccinia Virus Cap-2’-O-Methyltransferase / PAP-S, His Tag

This product is in development. If you are interested in this product, please contact us directly. We will accelerate our R&D process according to your needs and reserve the product for you.

User Reviews
Product Number/Spec
Price
Availability
Menge
CAE-V5141-2500U
$ 50.00
Gesamtanzahl Product Amount$ 0

Product Details

分子别名(Synonym)

PAP-S,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,VP39,Poly(A) polymerase regulatory subunit,Full=Poly(A) polymerase small subunit

表达区间及表达系统(Source)

Vaccinia Virus Cap-2’-O-Methyltransferase, His Tag (CAE-V5141) is expressed from E. coli cells. It contains AA Met 1 - Lys 333 (Accession # Q76ZT1.1).

Predicted N-terminus: Met

蛋白结构(Molecular Characterization)

Online-Res(Met 1 - Lys 333) Q76ZT1.1

This protein carries a polyhistidine tag at the N-terminus.

The protein has a calculated MW of 41.1 kDa.

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

制剂(Formulation)

Please contact us for detailed information.

Contact us for customized product form or formulation.

存储(Storage)

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. The product MUST be stored at -70°C or lower upon receipt;
  2. -70°C for 3 months under sterile conditions.

Kunden haben auch angesehen

Data Display

 
 

User Reviews
Publish Comment

Background Introduction

Displays methyltransferase, positive regulation of the poly(A) polymerase and transcription elongation activities. Involved in the modification of both mRNA ends and in intermediate and late gene positive transcription elongation. At the mRNAs 5' end, methylates the ribose 2' OH group of the first transcribed nucleotide, thereby producing a 2'-O-methylpurine cap. At the 3' end, functions as a processivity factor which stimulates the activity of the viral poly(A) polymerase VP55 that creates mRNA's poly(A) tail. In the presence of VP39, VP55 does not dissociate from the RNA allowing tail elongation to around 250 adenylates.

 

Frontier Progress

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • Data Display
  • User Reviews
  • Hintergrund
Kontaktieren Sie uns